The central risk is not product validity but shareholder capture. BlackSky has real demand and a real asset base, yet the path to value is narrow: it must keep deploying
Gen-3 on schedule, convert wins into recognized recurring revenue, and finance growth without letting
dilution or debt absorb the upside. Regulatory gates and customer concentration raise the fragility of that path.